209 related articles for article (PubMed ID: 34755388)
1. A group-sequential randomized trial design utilizing supplemental trial data.
Kotalik A; Vock DM; Hobbs BP; Koopmeiners JS
Stat Med; 2022 Feb; 41(4):698-718. PubMed ID: 34755388
[TBL] [Abstract][Full Text] [Related]
2. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
Harun N; Liu C; Kim MO
Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
[TBL] [Abstract][Full Text] [Related]
3. A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.
Zhang W; Pan Z; Yuan Y
J Biopharm Stat; 2022 May; 32(3):359-372. PubMed ID: 35679137
[TBL] [Abstract][Full Text] [Related]
4. Bayesian group sequential designs for phase III emergency medicine trials: a case study using the PARAMEDIC2 trial.
Ryan EG; Stallard N; Lall R; Ji C; Perkins GD; Gates S
Trials; 2020 Jan; 21(1):84. PubMed ID: 31937351
[TBL] [Abstract][Full Text] [Related]
5. Optimal timing for an accelerated interim futility analysis incorporating real world data.
Haine LMF; Murray TA; Koopmeiners JS
Contemp Clin Trials; 2024 May; 140():107489. PubMed ID: 38461938
[TBL] [Abstract][Full Text] [Related]
6. Bayesian basket trial design with false-discovery rate control.
Zabor EC; Kane MJ; Roychoudhury S; Nie L; Hobbs BP
Clin Trials; 2022 Jun; 19(3):297-306. PubMed ID: 35128970
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling.
Wei W; Blaha O; Esserman D; Zelterman D; Kane M; Liu R; Lin J
Stat Med; 2024 May; 43(12):2439-2451. PubMed ID: 38594809
[TBL] [Abstract][Full Text] [Related]
8. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
[TBL] [Abstract][Full Text] [Related]
9. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
Ji Z; Lin J; Lin J
J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
[TBL] [Abstract][Full Text] [Related]
10. Adaptive designs in critical care trials: a simulation study.
Li W; Cornelius V; Finfer S; Venkatesh B; Billot L
BMC Med Res Methodol; 2023 Oct; 23(1):236. PubMed ID: 37853343
[TBL] [Abstract][Full Text] [Related]
11. Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.
Wang Y; Travis J; Gajewski B
BMC Med Res Methodol; 2022 Apr; 22(1):118. PubMed ID: 35448963
[TBL] [Abstract][Full Text] [Related]
12. Calibrated dynamic borrowing using capping priors.
Ling SX; Hobbs BP; Kaizer AM; Koopmeiners JS
J Biopharm Stat; 2021 Nov; 31(6):852-867. PubMed ID: 35129422
[TBL] [Abstract][Full Text] [Related]
13. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
Quan H; Zhang B; Lan Y; Luo X; Chen X
Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
[TBL] [Abstract][Full Text] [Related]
14. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.
Daniells L; Mozgunov P; Bedding A; Jaki T
Stat Med; 2023 Oct; 42(24):4392-4417. PubMed ID: 37614070
[TBL] [Abstract][Full Text] [Related]
15. Bayesian clinical trial design using historical data that inform the treatment effect.
Psioda MA; Ibrahim JG
Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
[TBL] [Abstract][Full Text] [Related]
16. Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach.
Feißt M; Krisam J; Kieser M
Pharm Stat; 2020 Sep; 19(5):662-678. PubMed ID: 32227680
[TBL] [Abstract][Full Text] [Related]
17. Using Bayesian adaptive designs to improve phase III trials: a respiratory care example.
Ryan EG; Bruce J; Metcalfe AJ; Stallard N; Lamb SE; Viele K; Young D; Gates S
BMC Med Res Methodol; 2019 May; 19(1):99. PubMed ID: 31088354
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Bayesian and frequentist group-sequential clinical trial designs.
Stallard N; Todd S; Ryan EG; Gates S
BMC Med Res Methodol; 2020 Jan; 20(1):4. PubMed ID: 31910813
[TBL] [Abstract][Full Text] [Related]
19. Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.
Su L; Chen X; Zhang J; Yan F
JCO Precis Oncol; 2022 Mar; 6():e2100394. PubMed ID: 35263169
[TBL] [Abstract][Full Text] [Related]
20. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
Moatti M; Chevret S; Zohar S; Rosenberger WF
Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]